C. Papavassilis

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Richard G. Langley, Boni E. Elewski, Mark Lebwohl et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

Kim Papp, Richard G. Langley, Bárður Sigurgeirsson et al. · British Journal of Dermatology · 2012 · 356 citations

Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)

Andrew Blauvelt, Jörg C. Prinz, Alice B. Gottlieb et al. · British Journal of Dermatology · 2014 · 317 citations

Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis

P.C.M. van de Kerkhof, C.E.M. Griffiths, Kristian Reich et al. · Journal of the American Academy of Dermatology · 2016 · 303 citations

Inflammation, Iii Clinical Studies, Autoimmune Disease +8

Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (<scp>JUNCTURE</scp>)

C. Paul, J.‐P. Lacour, L. Tedremets et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 275 citations